Cadrenal Therapeutics Inc (CVKD)
0.4103
-0.02
(-4.60%)
USD |
NASDAQ |
May 17, 16:00
0.4103
0.00 (0.00%)
After-Hours: 20:00
Cadrenal Therapeutics Free Cash Flow: -3.954M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -3.954M |
| December 31, 2023 | -3.530M |
| Date | Value |
|---|---|
| September 30, 2023 | -2.880M |
Free Cash Flow Range, Past 5 Years
-3.954M
Minimum
Mar 2024
-2.880M
Maximum
Sep 2023
-3.455M
Average
-3.530M
Median
Dec 2023
Free Cash Flow Benchmarks
| CEL-SCI Corp | -20.40M |
| AIM ImmunoTech Inc | -21.85M |
| IGC Pharma Inc | -6.55M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Protalix BioTherapeutics Inc | 4.369M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.836M |
| Cash from Financing (Quarterly) | 0.0003M |
| Free Cash Flow Per Share (Quarterly) | -0.1147 |
| Free Cash Flow Yield | -65.03% |